Table III.
Relationship between demographic, clinical and biochemical factors and body fat level
| Variable | Body fat | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| All | EP + LP | P | |||||||
| Low (n = 144) | High (n = 156) | pb | Low (n = 68) | High (n = 75) | pb | Low (n = 69) | High (n = 88) | pb | |
| Age [years] | 53 (44–66) | 54 (44–64) | 0.1472 | 49 | 49 | 0.3032 | 56.00 | 57.00 | 0.2855 |
| Height [cm] | 164 (146–180) | 163 (138–176) | 0.0001 | 165 | 163 | 0.0023 | 164.00 | 163.50 | 0.0233 |
| Weight [kg] | 67 (42–146) | 71 (45–98) | 0.0003 | 69 | 70 | 0.2408 | 67.00 | 72.50 | 0.0030 |
| BMI [kg/m2] | 24.3 (16.8–46.6) | 26.8 (18.8–44.6) | < 0.0001 | 24.3 | 26.6 | 0.0282 | 24.34 | 27.08 | 0.0001 |
| WHR | 0.78 (0.69–0.94) | 0.85 (0.70–0.98) | < 0.0001 | 0.78 | 0.85 | < 0.0001 | 0.78 | 0.84 | < 0.0001 |
| Waist circumference [cm] | 80 (64–108) | 90 (68–120) | < 0.0001 | 80 | 90 | < 0.0001 | 80.00 | 91.00 | < 0.0001 |
| Hip circumference [cm] | 102 (84–136) | 107 (88–136) | < 0.0001 | 102 | 107 | 0.0136 | 102.00 | 108.00 | < 0.0001 |
| Neck circumference [cm] | 35 (28–44) | 36 (30–44) | 0.0001 | 34 | 36 | 0.0093 | 35.00 | 36.00 | 0.0031 |
| PFI | 50.6 (30.4–73.2) | 51.1 (30.1–73.6) | 0.3216 | 50.0 | 50.0 | 0.9088 | 50.8 | 51.9 | 0.2799 |
| Total cholesterol [mg/dl] | 211.5 (119–335) | 213 (129–330) | 0.7047 | 86 | 89 | 0.2330 | 223.00 | 217.00 | 0.3396 |
| HDL [mg/dl] | 67 (34–112) | 63 (38–114) | 0.0679 | 66 | 63 | 0.7054 | 67.00 | 62.50 | 0.0296 |
| LDL [mg/dl] | 122.7 (53.4–248.8) | 128.3 (55.4–224.8) | 0.7588 | 115.6 | 120 | 0.5009 | 136.40 | 135.20 | 0.4069 |
| TG [mg/dl] | 85.5 (23–256) | 94.5 (38–388) | 0.0113 | 86 | 89 | 0.2330 | 83.00 | 97.50 | 0.0215 |
| Glucose [mg/dl] | 89 (64–210) | 90 (69–202) | 0.1200 | 90 | 90 | 0.6145 | 87.00 | 91.00 | 0.0064 |
| LH [mIU/ml] | 28.9 (1.2–96.6) | 25.8 (0.6–107.6) | 0.3490 | 8.5 | 5.5 | 0.0521 | 36.10 | 32.25 | 0.0482 |
| FSH [mIU/ml] | 52.6 (1.5–133.7) | 54.9 (2.2–155.8) | 0.5578 | 10.7 | 9.4 | 0.1192 | 83.04 | 74.47 | 0.0258 |
| E2 [pg/ml] | 20 (10–480) | 23 (12–482) | 0.3368 | 64 | 85.5 | 0.6062 | 15.00 | 13.50 | 0.6106 |
| PGN [ng/ml] | 0.28 (0.15–20.8) | 0.36 (0.15–23.3) | 0.0141 | 0.66 | 0.49 | 0.6375 | 0.26 | 0.17 | 0.0090 |
| TTE [ng/dl] | 31.9 (10–81.9) | 33 (7.4–91.2) | 0.8562 | 31.4 | 34.4 | 0.8446 | 33.08 | 29.10 | 0.9676 |
| TSH [µIU/ml] | 1.44 (0.16–6.35) | 1.32 (0.11–7.19) | 0.1899 | 1.34 | 1.54 | 0.2611 | 1.26 | 1.35 | 0.4079 |
| FT3 [pg/ml] | 3.2 (2.4–3.9) | 3.2 (2.1–5) | 0.2105 | 3.2 | 3.2 | 0.0304 | 3.20 | 3.20 | 0.5631 |
| FT4 [ng/dl] | 1.09 (0.75–1.53) | 1.12 (0.72–1.57) | 0.6718 | 1.1 | 1.1 | 0.7958 | 1.09 | 1.11 | 0.7130 |
| Cortisol [µg/dl] | 11.3 (4.1–29.6) | 11.8 (4.8–34.9) | 0.0943 | 11.7 | 10.8 | 0.2362 | 12.80 | 11.65 | 0.1566 |
| ACTH [ng/l] | 12.1 (1.01–50.8) | 11.3 (1–33.0) | 0.2042 | 12.4 | 11.1 | 0.3142 | 11.93 | 11.35 | 0.4129 |
| Myostatin [ng/ml] | 7.0 (1.1–14.3) | 5.5 (0.8–15.1) | 0.0269 | 7.7 | 5.6 | 0.1837 | 6.2 | 5.0 | 0.0790 |
Body fat was expressed as median and range (%), Low body fat: groups I–III, high body fat: groups IV-V, pb – Mann-Whitney U-test (non-parametric), EP – early perimenopause, LP – late perimenopause, P – postmenopause, BMI – body mass index, WHR – waist-hip ratio, HDL – high-density lipoprotein, LDL – low-density lipoprotein, TG – triglyceride, LH – luteinizing hormone, FSH – follicle-stimulating hormone, E2 – estradiol, PGN – progesterone, TTE – testosterone, TSH – thyroid-stimulating hormone, FT3 – triiodothyronine, FT4 – thyroxine, ACTH – adrenocorticotropic hormone, PFI – physical fitness index.